Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...

Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma (HCC), but real-world outcomes remain heavily constrained by liver function ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

Learn how weight loss, diet changes and regular exercise can help manage — and sometimes reverse — fatty liver disease when ...

Margot got the news in her early 20s: "You have liver cancer," her doctors told her. Specifically, Margot had a form of liver cancer known as fibrolamellar carcinoma, a diagnosis with deadly prospects ...

More than 30% of people worldwide have metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease), including 65% of those with type 2 diabetes (T2D) ...

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern ...

People with twice as much of the forever chemicals PFOA - found in non-stick cookware - and fire fighting PFHpA in their ...